Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

11
June Cha staff
June Cha
June Cha is a policy director at FasterCures, MI Health.
Apr 23, 2024
FasterCures Quarterly Update—April 2024 article
FasterCures Quarterly Update—April 2024
In This Newsletter New FasterCures Team Member Policy Updates Events and Convenings Recap FasterCur
es in the Community
Apr 11, 2024
MI Health landing page
MI Health
MI Health bridges innovation gaps across the health and health-care continuum. We advance whole-pers
on health throughout the life span by improving healthy aging, public health, biomedical science, and food systems., Future of Health Summit Panels The Milken Institute Future of Health Summit brought together hundreds of leaders from across sectors to discuss critical issues and solutions within reach for , ,
Apr 23, 2024
The 2024-2025 FasterCures LeadersLink Cohort article
The 2024-2025 FasterCures LeadersLink Cohort
The 2024–2025 FasterCures’ LeadersLink program cohort has been carefully selected from a highly comp
etitive pool of candidates.
Apr 23, 2024
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation article
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutt
ing-edge biomedical innovations to patients.
Nov 16, 2021
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development report
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering&nbsp
;the market and can identify multiple cancers early and simultaneously.
Nov 3, 2021
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
Nov 19, 2021
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem report
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem
Clinical trials have been used for decades as the primary way by which researchers determine if a n
ew treatment is safe and effective for human use.
Nov 18, 2021
TRAIN Newsletter — April 2024 article
TRAIN Newsletter — April 2024
TRAIN eNews is delivered directly to organizations participating in The Research Acceleration and In
novation Network (TRAIN).
Apr 22, 2024
Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561 article
Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561
Lauren K. Roth Associate Commissioner for Policy Food and Drug Administration 5630 Fishers Lane, Rm.
1061 Rockville, MD 20852 Dear Ms. Roth,
Apr 29, 2024
Building Impactful, Transparent, and Reciprocal Relationships with Industry Partners video
Building Impactful, Transparent, and Reciprocal Relationships with Industry Partners
How can patient organizations hoping to leverage the resources of industry researchers attract the
ir support and establish formal industry partnerships?
Apr 3, 2024